MYDGF
Basic information
Region (hg38): 19:4641374-4670362
Previous symbols: [ "IL27", "IL27w", "C19orf10" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (23 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MYDGF gene is commonly pathogenic or not. These statistics are base on transcript: NM_000019107.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 23 | 23 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
Total | 0 | 0 | 23 | 0 | 0 |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MYDGF | protein_coding | protein_coding | ENST00000262947 | 6 | 28997 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000349 | 0.365 | 125723 | 0 | 22 | 125745 | 0.0000875 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.857 | 71 | 94.4 | 0.752 | 0.00000513 | 1090 |
Missense in Polyphen | 30 | 33.499 | 0.89556 | 386 | ||
Synonymous | -0.769 | 48 | 41.7 | 1.15 | 0.00000260 | 333 |
Loss of Function | 0.385 | 9 | 10.3 | 0.871 | 5.40e-7 | 107 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000212 | 0.000212 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000618 | 0.0000615 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.000163 | 0.000163 |
Other | 0.000659 | 0.000652 |
dbNSFP
Source:
- Function
- FUNCTION: Bone marrow-derived monocyte and paracrine-acting protein that promotes cardiac myocyte survival and adaptive angiogenesis for cardiac protection and/or repair after myocardial infarction (MI). Stimulates endothelial cell proliferation through a MAPK1/3-, STAT3- and CCND1-mediated signaling pathway. Inhibits cardiac myocyte apoptosis in a PI3K/AKT-dependent signaling pathway (By similarity). Involved in endothelial cell proliferation and angiogenesis (PubMed:25581518). {ECO:0000250|UniProtKB:Q9CPT4, ECO:0000269|PubMed:25581518}.;
- Pathway
- XBP1(S) activates chaperone genes
(Consensus)
Recessive Scores
- pRec
- 0.138
Intolerance Scores
- loftool
- rvis_EVS
- 0.22
- rvis_percentile_EVS
- 67.92
Haploinsufficiency Scores
- pHI
- 0.0846
- hipred
- N
- hipred_score
- 0.370
- ghis
- 0.484
Essentials
- essential_gene_CRISPR
- essential_gene_CRISPR2
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- gene_indispensability_score
Mouse Genome Informatics
- Gene name
- Mydgf
- Phenotype
- immune system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- angiogenesis;positive regulation of protein phosphorylation;positive regulation of endothelial cell proliferation;apoptotic process;positive regulation of phosphatidylinositol 3-kinase signaling;IRE1-mediated unfolded protein response;negative regulation of apoptotic process;positive regulation of MAPK cascade;positive regulation of angiogenesis;positive regulation of transcription by RNA polymerase II;positive regulation of protein kinase B signaling
- Cellular component
- extracellular space;endoplasmic reticulum lumen;endoplasmic reticulum-Golgi intermediate compartment
- Molecular function
- protein binding